THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $873,000 | – | 29,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 750,000 | $12,293,000 | 4.39% |
| Baupost Group | 19,815,983 | $208,860,000 | 3.79% |
| Clearline Capital LP | 1,591,705 | $16,777,000 | 2.60% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,530,104 | $26,667,000 | 1.49% |
| Empyrean Capital Partners, LP | 3,538,858 | $37,300,000 | 1.38% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 12,419,845 | $130,905,000 | 1.08% |
| Partner Investment Management, L.P. | 51,387 | $542,000 | 0.89% |
| PFM Health Sciences, LP | 2,311,681 | $24,365,000 | 0.74% |
| Diligent Investors, LLC | 36,470 | $384,000 | 0.43% |
| Roundview Capital LLC | 99,235 | $1,046,000 | 0.41% |